Amanote Research

Amanote Research

    RegisterSign In

Treatment of Moderately to Severely Active Systemic Lupus Erythematosus With Adrenocorticotropic Hormone: A Single-Site, Open-Label Trial

Lupus - United Kingdom
doi 10.1177/0961203314532562
Full Text
Open PDF
Abstract

Available in full text

Categories
Rheumatology
Date

May 2, 2014

Authors
JJ FiechtnerT Montroy
Publisher

SAGE Publications


Related search

Frentizole Therapy of Active Systemic Lupus Erythematosus

Arthritis & Rheumatism
1980English

Steroid Treatment of Systemic Lupus Erythematosus

Ensho
1982English

SAT0231 Safety of Subcutaneous Belimumab in Patients With Systemic Lupus Erythematosus: A 6-Month Open-Label Extension Study

2017English

Integral Treatment of Systemic Lupus Erythematosus

2011English

Treatment Satisfaction in Systemic Lupus Erythematosus

Journal of Clinical Rheumatology
MedicineRheumatology
2017English

Correction To: Psoriasis in Systemic Lupus Erythematosus: A Single-Center Experience

Clinical Rheumatology
MedicineRheumatology
2018English

Systemic Lupus Erythematosus

JAMA - Journal of the American Medical Association
Medicine
2011English

Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis

Journal of Immunology Research
MedicineAllergyImmunology
2017English

Systemic Lupus Erythematosus

Deutsche Medizinische Wochenschrift
Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy